These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7892748)
21. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406 [TBL] [Abstract][Full Text] [Related]
22. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF J Immunol; 1996 Mar; 156(5):1714-21. PubMed ID: 8596018 [TBL] [Abstract][Full Text] [Related]
23. Dipeptidylpeptidase IV in human leukemic B- and T-cells. Bylinkina VS; Lokshina LA; Samojlova RS; Lubkova ON; Gureeva TA; Golubeva NV Biochem Int; 1992 Oct; 28(1):31-9. PubMed ID: 1359891 [TBL] [Abstract][Full Text] [Related]
24. Thymocyte costimulating antigen is CD26 (dipeptidyl-peptidase IV). Costimulation of granulocyte, macrophage, and T lineage cell proliferation via CD26. Bristol LA; Sakaguchi K; Appella E; Doyle D; Takács L J Immunol; 1992 Jul; 149(2):367-72. PubMed ID: 1352525 [TBL] [Abstract][Full Text] [Related]
25. Dipeptidyl peptidase IV: development, design, synthesis and biological evaluation of inhibitors. Borloo M; De Meester I Verh K Acad Geneeskd Belg; 1994; 56(1):57-88. PubMed ID: 7911611 [TBL] [Abstract][Full Text] [Related]
26. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells. Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567 [TBL] [Abstract][Full Text] [Related]
27. Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes. De Meester I; Vanhoof G; Hendriks D; Demuth HU; Yaron A; Scharpé S Clin Chim Acta; 1992 Sep; 210(1-2):23-34. PubMed ID: 1358482 [TBL] [Abstract][Full Text] [Related]
28. The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes. Schön E; Mansfeld HW; Demuth HU; Barth A; Ansorge S Biomed Biochim Acta; 1985; 44(2):K9-15. PubMed ID: 2860900 [TBL] [Abstract][Full Text] [Related]
29. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. Reinhold D; Bank U; Bühling F; Neubert K; Mattern T; Ulmer AJ; Flad HD; Ansorge S Immunobiology; 1993 Aug; 188(4-5):403-14. PubMed ID: 7902330 [TBL] [Abstract][Full Text] [Related]
30. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Torimoto Y; Dang NH; Tanaka T; Prado C; Schlossman SF; Morimoto C Mol Immunol; 1992 Feb; 29(2):183-92. PubMed ID: 1371820 [TBL] [Abstract][Full Text] [Related]
31. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. Ludwig A; Schiemann F; Mentlein R; Lindner B; Brandt E J Leukoc Biol; 2002 Jul; 72(1):183-91. PubMed ID: 12101279 [TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl peptidase 8/9-like activity in human leukocytes. Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297 [TBL] [Abstract][Full Text] [Related]
33. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Ulmer AJ; Mattern T; Feller AC; Heymann E; Flad HD Scand J Immunol; 1990 Apr; 31(4):429-35. PubMed ID: 1970666 [TBL] [Abstract][Full Text] [Related]
34. Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases. Van der Veken P; Senten K; Kertèsz I; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K J Med Chem; 2005 Mar; 48(6):1768-80. PubMed ID: 15771423 [TBL] [Abstract][Full Text] [Related]
35. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice. Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138 [TBL] [Abstract][Full Text] [Related]
36. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26. Nguyen C; Blanco J; Mazaleyrat JP; Krust B; Callebaut C; Jacotot E; Hovanessian AG; Wakselman M J Med Chem; 1998 Jun; 41(12):2100-10. PubMed ID: 9622551 [TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression. Klobusická M; Babusíková O Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667 [TBL] [Abstract][Full Text] [Related]
38. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233 [TBL] [Abstract][Full Text] [Related]
39. CD26 and DPP IV expression in T acute lymphoblastic leukemia cells: immunocytochemistry and enzyme cytochemistry. Klobusická M; Babusíková O Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():34-7. PubMed ID: 10707830 [TBL] [Abstract][Full Text] [Related]
40. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase. Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]